Key Insights

Highlights

Treatment Research

3 treatments under study, led by Budesonide

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Early Phase 1 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT04267042Early Phase 1Unknown

Comparing Budesonide Via MAD or INSI Prospective Cohort Study

Showing all 1 trials

Research Network

Common Treatments

  • Budesonide1
  • Neilmed Squeeze Bottle For Impregnated Nasal Saline Irrigation1
  • Mucosal Atomization Device1

Active Sponsors

  • St. Paul's Hospital, Canada1

Top Investigators

  • Amin Javer, MD1

    The University of British Columbia and St. Paul's Sinus Centre

Related Conditions

  • Chronic Rhinosinusitis With Nasal Polyps1

Activity Timeline